Implant including a coil and a stretch-resistant member

Abstract
This invention is directed to implantable coils and, more particularly, to a coil implant having a stretch-resistant member internal to the coil. The implant of the invention is able to freely articulate and torque prior to delivery. Once delivered, the implant is no longer stretch resistant and is therefore able to substantially conform to the vascular site.
Description
FIELD OF THE INVENTION

This invention relates to implantable coils and, more particularly, to a coil implant having a stretch-resistant member internal to the coil.


BACKGROUND OF THE INVENTION

Implants are delivered to a vascular site, such as an aneurysm, of a patient via a microcatheter to occlude or embolize the vascular site. Typically, the implant is engaged at the distal end of either the delivery microcatheter or the guidewire contained within the microcatheter and controllably released therefrom into the vascular site to be treated. The clinician delivering the implant must navigate the microcatheter or guide catheter through the vasculature and, in the case of intracranial aneurysms, navigation of the microcatheter is through tortuous microvasculature. This delivery may be visualized by fluoroscopy or another suitable means. Once the distal tip of the catheter or guidewire is placed in the desired vascular site, the clinician must then begin to articulate the implant in the vascular site to ensure that the implant will be positioned in a manner to sufficiently embolize the site. Once the implant is appropriately positioned, the clinician must then detach the implant from the catheter or guidewire without distorting the positioning of the implant. Detachment may occur through a variety of means, including, chemical detachment, mechanical detachment, hydraulic detachment, and thermal detachment.


The procedure of delivering the implant to the vascular site can be complicated for a number of reasons. One common complication found with implants of the art is that the doctor is not able to effectively articulate, rotate, and/or control the implant during positioning in the vascular site to provide sufficient embolization. One reason that the implant may not be able to effectively articulate is that the proximate portion of the implants of the art are often rigid. This portion is referred to as the “stiff zone” and may also contain the detachment mechanism. One drawback of an implant having a “stiff zone” is that this “stiff zone” may cause catheter kick-out after deployment of the implant to the vascular site.


Another complication with implants of the art is that the implant may not be able to substantially conform to the vascular site due the presence of a stretch-resistant member. For example, U.S. Pat. No. 5,582,619 teaches a stretch-resistant member that is fixedly attached at both ends or at one end and then at another point in the lumen of the catheter. Due to the stretch-resistant member being fixedly attached in two locations, the implant, after delivery, will maintain some stretch-resistant properties. If the implant is stretch resistant after delivery, this may inhibit the implant's ability to substantially conform to the vascular site.


Yet another complication with implants of the art is that after detachment, the implant may contain a traumatic (or sharp) portion or stem. This traumatic portion most frequently occurs with implants that are mechanically or electrolytically detached from the delivery device. See, for example, U.S. Publ. 2004/0034363 which describes use of a stretch-resistant member and a loop at the proximal end of the coil. The loop, after deployment, is a traumatic portion. The traumatic portion may cause damage to the patient in the surrounding vasculature. Further, it is also contemplated that due to the presence of the loop, the clinician is not able to torque the implant during delivery therefore making the appropriate placement more difficult.


In light of the above, there exists a need for an implant that maintains the ability to freely articulate and torque without having a “stiff zone,” and also for the implant to substantially conform to the vascular site. There also exists a need to have an implant without a traumatic portion or stem after detachment at the vascular site.


SUMMARY OF THE INVENTION

The invention is directed to, in one embodiment, an implant with a stretch-resistant member.


The implant further includes a member for engaging a positioning device or a positioner. The member for engaging a positioning device and the stretch-resistant member are coupled together. The member for engaging a positioning device is free to move with respect to the coil thereby allowing for the implant to articulate and be positioned more accurately. In one embodiment, the implant includes a primary coil that defines a lumen disposed on an axis. A proximal end of the primary coil defines a proximal aperture, and a distal end of the primary coil defines a distal aperture. A stretch-resistant member is disposed in the lumen, with a coupling portion of the stretch-resistant member coupled in the lumen to the member for engaging a positioning device that has an engagement portion exterior to the lumen. The stretch-resistant member can be a line, a filament, or a braid.


The implant optionally can include a secondary coil. In one embodiment, the secondary coil is disposed at least in part in the lumen, and that further defines the proximal aperture. The secondary coil is coaxial with the primary coil.


The coupling portion of the stretch-resistant member can be coupled to a distal end of the member for engaging a positioning device which can preferably be an eyelet. The stretch-resistant member can also couple to the engagement member with a wrap or a knot, and can also extend back to the distal end of the primary coil so that two lengths of line extend along the length of the lumen. The line can also have an end that engages a retainer at the distal end of the primary coil. In one embodiment, the retainer is ball-shaped or rounded.


The member for engaging a positioning device can preferably be a rod and have a proximal end with an engagement portion, and the engagement portion can preferably be a ball mounted on the proximal end of the member for engaging a positioning device. The member for engaging a positioning device can also extend through the proximal aperture so that the engagement portion is disposed at the proximal-most end of the implant. The member for engaging a positioning device and the coupling portion of the stretch-resistant member can be freely disposed at the proximal end of the implant so that the member for engaging a positioning device and the coupling portion are not connected to or attached to the primary or secondary coils. Also, the member for engaging a positioning device can have a central axis that intersects the proximal aperture at various points. The member and engagement portion are free to move distally into the lumen of the primary (or primary and secondary) coil. In one embodiment, the member and engagement portion can move distally to be completely in the lumen of the coil.


In another embodiment, the invention is directed to a method of embolizing vascular site in a patient. The implant is introduced to the vascular site via a positioner and then detached from the positioner thereby embolizing the vascular site. The implant can be detached from the positioner by chemical detachment, electrolytic detachment, mechanical detachment, hydraulic detachment, or thermal detachment. After detachment, the engagement portion is contained within the interior lumen. In one embodiment, the engagement portion is completely contained within the interior lumen.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate exemplary embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain the features of the invention.



FIG 1A is a plan view of an exemplary positioning system and a plan view of an exemplary implant.



FIG. 1B is a closer view of a portion of FIG. 1A.



FIG. 2 is a plan view of a positioning system of FIG. 1 within the human body.



FIG. 3 is a partial cross-sectional plan view of the implant of FIG. 1 with an exemplary positioning device.



FIG. 4A is a closer view of a portion of FIG. 2 showing the positioning system in partial cross-section and an exemplary implant in a position within the human body prior to deployment of the implant.



FIG. 4B is a closer view of a portion of FIG. 2 showing the positioning system in partial cross-section and an exemplary implant in another position within the human body after deployment but before detachment.



FIG. 5 is a partial cross-sectional plan view of an implant with a stretch-resistant member in partial cross-section.



FIGS. 6A and 6B show an implant of the invention prior to detachment (FIG. 6A) and after detachment (FIG. 6B) from the positioner in partial cross-section.



FIG. 7 is a plan view of an embodiment of the stretch-resistant member of FIG. 5.



FIG. 8A illustrates one embodiment, in plan view, an exemplary wrapping pattern of the fibers around the stretch resistant member.



FIG. 8B is a cross-sectional view of the wrapping pattern of the fibers around the stretch-resistant member shown in FIG. 8A.





DETAILED DESCRIPTION OF THE INVENTION

Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods, devices, and materials are now described. All publications and patent applications cited herein are incorporated herein by reference in their entirety. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.


It must be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.


Methods of Embolizing a Vascular Site

Prior to describing the embodiments of the implant of the invention, provided below is an embodiment of the invention related to embolizing a vascular site of a patient using an implant.


As illustrated in FIGS. 1A and 1B, the implant of the invention, in one embodiment, may be used with a positioning device 70 that may optionally include an actuator 90 operated by an operator, a positioning tube 76 engaging the actuator 90, and an implant interface 78 at the distal end of the positioning tube 76. A portion of the implant interface 78 engages a complementary portion of an implant 10. The positioning device 70 is more specifically described below in FIG. 3.


In the embodiment illustrated in FIGS. 1A and 1B, an operator uses a guide tube or guide catheter 12 to position a delivery tube or microcatheter 14 in a patient's vasculature, as illustrated in FIG. 2. The procedure involves inserting the guide catheter 12 into the patient's vasculature through an access point such as the groin, and directing the distal end 12a of the guide catheter 12 through the vascular system until it reaches the carotid artery. After removing a guide wire (not shown) from the guide catheter 12, a microcatheter 14 is inserted into the guide catheter 12 and the distal end 14a of the microcatheter 14 subsequently exits the guide catheter distal end 12a and is positioned near the target site 16, such as an aneurysm in the patient's brain.


As illustrated in FIGS. 4A and 4B, the microcatheter 14 includes microcatheter markers 15 and 15a that facilitate imaging of the distal end 14a of the microcatheter 14 with common imaging systems and, in the illustrated embodiment, the microcatheter markers 15 and 15a are made of a radiopaque material. After the distal end 14a reaches the target site 16, the positioning device 70 (as shown in FIG. 1A) of the illustrated embodiment is then inserted into the microcatheter 14 to position the implant interface 78 at the distal end of the positioning device 70 near the target site 16, as illustrated in FIG. 4B.


If the implant 10 is being delivered in the procedure, the implant 10 is attached to the implant interface 78 prior to inserting the positioning device 70 into the microcatheter 14. This mode of implant delivery is illustrated in FIGS. 2 and 4A-B. The delivery of the implant 10 is facilitated by disposing the microcatheter marker 15a near the target site 16, and aligning the microcatheter marker 15 with a positioner marker 15b in the positioner tube 76 which, when the two markers (markers 15 and 15b) are aligned with each other as illustrated in FIG. 4B, indicates to the operator that the implant interface 78 is in the proper position for the release of the implant 10 from the positioning device 70. After depositing the implant 10 at the target site 16, a second implant 10 can be deposited at the target site 16 by removing the positioning device 70 from the microcatheter 14 and inserting a second positioning device 70 with an attached second implant 10 into the microcatheter 14 in a manner similar to the method used with the insertion of the first implant 10. The same procedure can be used for a third implant 10 and subsequent implants if clinically necessary. If the implant 10 is already in the patient's body to be retrieved or repositioned, the positioning device 70 is inserted into the microcatheter 14 without the implant 10.


As can be seen in FIG. 4A and FIG. 4B, it is advantageous that the implant 10 and positioning device 70 (not shown) have a reduced “stiff zone” at the interface 78 to better allow delivery through the tortuous vasculature, responsive placement into the target site 16, and for the ability to reposition the implant 10.


Implant and Device Configurations

The implant of the invention maintains a high level of articulation, including the ability to torque, prior to deployment thereby providing responsive placement and repositioning prior to deployment. This level of articulation is partially due to a lack of having or having a very small “stiff zone” in its proximal end. Further and as explained below, in one embodiment, the implant of the invention is stemless after detachment. As a result of the implant being stemless, the level of trauma associated with deployment of an implant in the vasculature is minimized.


Additionally, as described below, the implant of the invention has a stretch-resistant member and this feature eases delivery by allowing the clinician to reposition as necessary without the implant deforming while maintaining its secondary shape. After the implant of the invention is delivered, the implant of the invention no longer retains its “stretch resistance” properties thereby allowing the implant to better substantially conform to the vascular site.


The implant 10 illustrated in FIG. 5 includes a primary coil 20, a secondary coil 30, a stretch-resistant member 40, a retainer 50, and a member 60 for engaging a positioning device 70 (shown in FIGS. 1A, 1B, and 3). The member 60 for engaging a positioning device 70 is preferably a rod that includes a ball 62 and an eyelet 64.


The primary coil 20 has a proximal end 22 and a distal end 24 defining an internal lumen 26 extending between the ends of the primary coil. The primary coil 20 can be formed in a variety of shapes once heat setting of the coil form is performed. One such shape of the primary coil can be found in U.S. Ser. No. 12/038,737, filed on even date herewith and titled “An implant, a mandrel, and a method of forming an implant.” This application is incorporated by reference into its entirety.


The optional secondary coil 30 is disposed at the proximal end 22 of the primary coil 20 and further defines the proximal aperture. In one embodiment, the secondary coil 30 has an outer diameter that is sized to fit within the internal lumen 26 of the primary coil 20 and the primary coil 20 partially envelops the secondary coil 30. In this embodiment, the secondary coil 30 has an outer diameter which is less than the inner diameter of the primary coil 20. In another embodiment, the secondary coil 30 has an outer diameter equal or less than the outer diameter of the primary coil 20. In another embodiment, the secondary coil 30 is adjacent to the primary coil 20. The secondary coil 30 may be affixed by any means, such as welded, to the proximal end 22 of the primary coil 20 with weld 36, with a distal portion 34 of the secondary coil 30 disposed within the internal lumen 26 and a proximal portion 32 disposed proximal to the primary coil 20.


The retainer 50 engages the distal end 24 of the primary coil 20. The retainer 50, if present, is shaped such that there is minimized trauma to the vascular site upon delivery. In certain embodiments, the retainer 50 is ball-shaped. In some embodiments, the retainer 50 is rounded on the portion that is exterior to the lumen 26 and the diameter of the retainer 50 is equal to or slightly less that than the outer diameter of the primary coil 20. The stretch-resistant member 40 is disposed in the internal lumen 26. A distal end 44 of the stretch-resistant member engages the retainer 50. A proximal end 42 of the stretch-resistant member 40 engages the eyelet 64 of the rod 60. The distal portion of the rod 60 and the eyelet 64 are disposed in the internal lumen 26. A proximal portion of the rod 60 and the ball 62 extends proximally from the internal lumen 26 and is disposed proximal to the primary and secondary coils 20 and 30. The rod 60 and the proximal end 42 of the stretch-resistant member 40 are not connected to or attached to the primary or secondary coils 20 and 30 and are free to move within the internal lumen 26 in the direction of the longitudinal axis of the implant 10 and to move so that the rod 60 can assume an angle relative to the longitudinal axis of the implant 10.


The proximal end 42 of the stretch-resistant member 40 and the eyelet 64 form a coupling that can comprise any type of connection. The stretch-resistant member 40 is preferably a single line 46 that extends from the retainer 50 to the eyelet 64, passes through the eyelet 64, and extends from the eyelet 64 to the retainer 50. The line 46 can also be a filament or a braid. When passing through the eyelet 64, the line 46 is preferably wrapped through the eyelet 64 to form a knot 48, and is most preferably formed as a hitch knot as illustrated in FIG. 7. Alternatively, the line 46 can be one or more separate lines that terminate at the eyelet 64 to form a coupling with the eyelet 64. In another alternative, the coupling can be formed in the stretch-resistant member 40 in a middle portion disposed between proximal and distal portions of the stretch-resistant member 40, such as with a knot coupling the proximal and distal portions of the stretch-resistant member 40 together within the internal lumen 26. In yet another alternative, the coupling can be a combination of a knot and a wrapping, or a combination of multiple lines 46 employing different couplings. The coupling can also involve the modification of the stretch-resistant member 40 at the point of coupling, such as by deforming or melting of the stretch-resistant member 40 to join the end of a line 46 back onto itself to form a closed loop. In still another alternative, an eyelet can be formed at the proximal end of the stretch-resistant member 40 that is coupled to the distal end of the rod 60, with the distal end of the rod 60 knotted to form the coupling, or with the distal end of the rod 60 deformed or melted back onto itself to form a closed loop.


The inner diameter of the secondary coil 30 is selected to engage the eyelet 64 and to engage the positioning device 70 (shown in FIG. 1A).


The rod 60 can have various cross-sectional shapes, such as a circular or triangular shape. The ball 62 can be replaced with another structure such as a disc, hook, or ring structure that preferably provides an external diameter or equivalent dimension comparable to the ball 62.


Fibers

The primary coil 20, secondary coil 30, and the stretch-resistant member 40 can also comprise at least one fiber 85. The fiber(s) 85 can be a plurality of fibers, at least one bundle of fibers, or a plurality of fiber bundles. The fiber(s) 85 can be enlaced, tied, or knotted to a number of places on the implant 10. The fibers or fiber bundles 85 can be disposed so that they are not tied or knotted to the implant 10, thereby avoiding potentially obstructive bundles that might hinder deployment of the implant 10 or might mechanically damage the implant 10. The use of fibers with coils is disclosed in U.S. Publ. No. 2006/0036281, which is incorporated by reference in its entirety.


In one embodiment illustrated in FIGS. 8A and 8B, the fiber 85 is wrapped at least one or two times around the stretch-resistant member 40. In one embodiment, the fiber(s) 85 include a plurality of fibers, at least one bundle of fibers, or a plurality of fiber bundles wrapped at least one or two times round the stretch-resistant member 40.


In another embodiment, the fiber(s) 85 are enlaced through a single loop around the primary coil 20 and optionally the secondary coil 30. In another embodiment, the fiber(s) 85 are enlaced through a pair of loops of the primary coil 20 and optionally the secondary coil 30. In yet another embodiment, the fiber(s) 85 are enlaced in a “S” pattern through a plurality of loops in the primary coil 20 and optionally the secondary coil 30. In still yet another embodiment, the fiber(s) 85 are enlaced adjacent to each other in a “S” pattern on the primary coil 20 and optionally the secondary coil 30.


Materials

The primary and secondary coils 20 and 30 and rod 60 are preferably made of a biocompatible metal or metal alloy wire that does not react adversely with tissues and fluids when used in the body. The wire may be round, square, oval, triangular, or another shape. In certain embodiments the wire commonly has a diameter of from about 0.025 to about 0.09 mm, from about 0.03 to about 0.08 mm from about 0.04 to about 0.06 mm In certain specific embodiments the wire has a diameter of about 0.05 mm. In some embodiments the wire may be comprised only of a primary shape e.g., a simple single helix. In some embodiments the wire component may comprise a primary shape e.g., helical coil and a secondary shape which the coil is biased to form upon release from the catheter or guidewire. The secondary shape may comprise a complicated three dimensional shape. These shapes include spherical, cubic and other space-filling shapes, such as those created by winding the wire in a series of mobius loops. This embodiment is described in can be found in U.S. Ser. No. 12/038,737, filed on even date herewith and titled “An implant, a mandrel, and a method of forming an implant.” This application is incorporated by reference in its entirety.


In other embodiments the wire can comprise a coil of coils or double helix. When it is a coil of coils, the outer or secondary diameter of the outer helix may be from about 1 to about 25 mm in some embodiments and from about 2 to 20 mm in certain other embodiments. The primary (inner) helix may typically have an outside diameter of from about 0.1 to about 0.8 mm in some embodiments, and from about 0.15 to about 0.6 mm in other embodiments and from about 0.2 to about 0.4 mm in yet other embodiments. Certain specific embodiments provide for coils having a primary diameter of about 0.28 mm sized to pass through a correspondingly dimensioned catheter. Yet other embodiments provide for coils having a primary diameter of about 0.24 mm sized to pass through a correspondingly dimensioned catheter.


In one embodiment, the material of the primary and secondary coils 20 and 30 and rod 60 are made of a material that may be heat set at a temperature of approximately 650° C. The metal or metal alloy can be radiopaque so that the position and location of the implant in the body can be monitored with radiological techniques. Suitable metals include, but are not limited to the noble metals such as the platinum group metals which include platinum, palladium, rhodium and rhenium as well as iridium, gold, silver, tungsten, and tantalum and alloys of these metals with one another. Additional metals include the super elastic metals such as “Nitinol” and the like. In one embodiment, the primary and secondary coils 20 and 30 are made of a platinum alloy, and the rod 60 is made of stainless steel.


The overall axial length of the implant 10 of this invention ranges from about 5 to about 400 mm in some embodiments and from about 10 to about 300 mm in other embodiments. This length may be selected depending upon the particular application of use and may be longer than about 400 mm in some embodiments.


The stretch-resistant member 40 and the retainer 50 are preferably made from a wide variety of materials. These materials can include any of the metals suitable for making the primary and secondary coils 20 and 30. The stretch-resistant member 40 and the retainer 50 can also be made of a radiopaque material, or of a polymer.


The stretch-resistant member 40, retainer 50, and fibers/fiber bundles 85 are preferably made of polymeric materials, and most preferably made of polypropylene. The retainer 50 is also preferably formed from a melt of the stretch-resistant member 40. The polymeric materials can include materials approved for use as implants in the body or which could be so approved. They can be nonbiodegradable polymers such as polyethylene, polyacrylics, polypropylene, polyvinylchloride, polyamides such as nylon, e.g., Nylon 6.6, polyurethanes, polyvinylpyrrolidone, polyvinyl alcohols, polyvinylacetate, cellulose acetate, polystyrene, polytetrafluoroethylene, polyesters such as polyethylene terephthalate (Dacron), silk, cotton, and the like. The nonbiodegradable materials for the polymer component can comprise polyesters, polyethers, polyamides and polyfluorocarbons.


The polymeric materials can be biodegradable as well. Representative biodegradable polymers include: polyglycolic acid/polylactic acid (PGLA), polycaprolactone (PCL), polyhydroxybutyrate valerate (PHBV), polyorthoester (POE), polyethyleneoxide/polybutylene terephthalate (PEO/PBTP), polylactic acid (PLA), polyglycolic acid (PGA), poly(p-dioxanone), poly(valerolactone), poly(tartronic acid), poly((3-malonic acid), poly(propylene fumarate), poly(anhydrides), and tyrosine-based polycarbonates. Other equivalent materials, including but not limited to stereoisomers of any of the aforementioned, may be used as well. The biodegradable polymer can be comprised of copolymers of lactic acid and glycolic acid. The copolymer can be comprised of glycolic/lactic acid in the ratio of 90:10. The ratio of glycolic to lactic acid can be chosen from 99:1; 90:10; 95:5; 50:50; 10:90; 5:95; and 1:99. The fibers can also be comprised of Nylon 6.6.


The stretch resistant member 40 and the fiber(s) 85 may also comprise a bioactive coating. The bioactive coating may be selected from growth factor, a gene, an oligonucleotide, a peptide, a marine biopolymer, a monosaccharide, a disaccharide, a polysaccharide, collagen and combinations thereof.


The illustrated stretch-resistant member 40 preferably has a tensile strength of 0.2 and 1.2 Newton. In some embodiments, the tensile strength is 0.6 Newton.


Positioning Device

The implant described herein may be delivered by a variety of suitable microcatheters and positioning devices. In one embodiment, the invention is directed to a kit having one or more implants of the invention and a positioning device. In another embodiment, the kit includes a microcatheter. Suitable microcatheters positioning devices are described in WO 2007/121405 entitled “System and Method For Mechanically Positioning Intravascular Implants” which is hereby incorporated by reference in its entirety.


In one embodiment, as illustrated in FIG. 3, the implant 10 can engage a positioning device 70 such that the ball 62 and the proximal portion of the rod 60 engage the distal end 74 of the positioning device 70. The illustrated positioning device 70 can include a positioner 75 with a positioner tube 76 having an actuator interface 77 and an implant interface 78 that terminates at an end cap 79. The end cap 79 can have a port 80 through which the rod 60 communicates with the positioner lumen 81. The positioner 75 can also include a cord 82 that occludes a portion of the port 80 to prevent the disengagement of the implant 10 from the implant interface 78.


It is believed that, because the stretch-resistant member 40 resists stretching, rod 60 is prevented from moving in the proximal direction out of the secondary coil 30. However, as can be seen in FIG. 6A, the stretch-resistant member 40, shown as line 46, remains sufficiently flexible to allow the rod 60 and the ball 62 to assume an angled position relative to the axis of the implant 10.


As can be seen in FIG. 6B, implant 10 can be mechanically released from positioning device 70 by retracting cord 82 so that the aperture of implant interface 78 is now sufficiently wide to permit ball 62 to traverse therethrough whereupon implant 10 is released into the vascular site. In this embodiment, ball 62 and rod 60 move in a distal direction relative to the primary coil as described below or the primary coil 20 and secondary coil 30 move proximally relative to the ball 62 and rod 60. Such movement places the ball 62 and rod 60 further into the internal lumen 26 within the primary coil 20, and in some embodiments fully enter the internal lumen 26 of the primary coil 20. In this case, ball 62 and rod 60 are fully engulfed within lumen 26 so as to form a stemless implant.


This flexibleness of the implant 10 of the invention reduces the amount of catheter kick-out. Catheter kick out refers to the movement of the catheter from its preformed shape after deployment of the implant and is typically measured by the angle of deflection, shown in FIG. 4B as 92. Implants of this invention typically have a catheter deflection of 40°, 30°, 20°, 19°, 15°, 10° or less. This reduction of catheter kick out is at least a 20%, 30%, 40%, 50%, and even 60% improvement over implants of the art.


It is also believed that, when the implant 10 is a neurological coil, the coil assumes two orientations, a microcatheter orientation when disposed in a microcatheter and a deployed orientation when external to the microcatheter. The transition of the coil from the microcatheter orientation to the deployed orientation is believed to cause the primary coil 20 to curve or bend and to extend slightly in length on at least one side of the primary coil 20, while the stretch-resistant member 40 does not so extend, thereby causing the proximal end of the implant 10 move relative to rod 60 and ball 62 and surround the rod and ball. This movement of the primary and secondary coils 20 and 30 relative to the rod 60 and ball 62, to enclose the rod and ball within the lumens of the coils 20 and 30, is believed to advantageously provide a structurally stable proximal implant end because any additional movement of the rod 60 and ball 62 is contained within the coils 20 and 30. It is further contemplated that the implant 10 is better able to conform to the desired vascular site.


Alternative Detachment Means

The implant may be deployed into the body by a number of means, including, but not limited to electrolytic detachment, chemical detachment, hydraulic detachment, thermal detachment, as well as other types of mechanical detachments. It is contemplated that the implant remains stemless after deployment into the body because after deployment, the rod 60 and ball 62 will be displaced in the inner lumen of the secondary coil 30. In other words, the ball 62 is drawn into the inner lumen of at least the secondary coil 30.


Electrolytic detachment may be performed by providing a weakened section at a junction between the implant 10 and the positioner 75. Regardless of the junction, due to the stretch-resistant member, the rod 60 and ball 62 will still be displaced in the inner lumen of the secondary coil 30 and possibly the primary coil 20. This weakened section may be easily vaporized by application an electric current. For example, the rod 60 and/or ball 62 may be replaced by a wire that may be detached by an electrical force, such as a 9V electric power source that can apply a current of about 0.3 milliamps for detachment. One example of an electrical detachment mechanism is described in U.S. Pat. No. 5,928,226, which is incorporated herein by reference.


With a chemical detachment mechanism, a dissolvable detachment section is included between the positioning device 70 and the implant 10 or at the distal end of the positioner 75. The dissolvable detachment section is dissolved, softened, swollen, degraded, or otherwise changed by the injection of a biocompatible chemical through the catheter. After the section is eroded, the rod 60 and ball 62 move distally into the lumen of the secondary coil 30 or the primary coil 20 and secondary coil 30. Some examples of chemical detachment systems include dissolvable detachment sections, such as a polymer section which is dissolved by dimethylsulfoxide, a nylon section which is dissolved by a fluorinated hydrocarbon, or sections which are dissolved by an aqueous saline solution or any of the other biocompatible solvents discussed above.


A hydraulic detachment mechanism may also be used with the implant of the invention. Hydraulic detachment means are within the scope of the art. In one embodiment, the implant interface 78 is formed of a material having a durometer such that when an appropriate fluid pressure is applied to the interior of the positioning device 70, the implant interface 78 expands thereby releasing the ball 62 and allowing the ball 62 to move distally into the lumen of the secondary coil and optionally the primary coil.


The implant of the invention may also be configured to be thermally detached from the positioner. This embodiment is similar to the electrolytic detachment described above; however, instead of applying an electric current, heat is applied thereby allowing the engagement portion to detach from the position 70 and move distally into the lumen of the catheter.


While the present invention has been disclosed with reference to certain embodiments, numerous modifications, alterations, and changes to the described embodiments are possible without departing from the sphere and scope of the present invention, as defined in the appended claims. Accordingly, it is intended that the present invention not be limited to the described embodiments, but that it has the full scope defined by the language of the following claims, and equivalents thereof.

Claims
  • 1. A coil implant, comprising: a first coil segment defining a first lumen having a first cross-sectional dimension;a second coil segment, having at least a portion extending within the first lumen, the second segment being connected to the first segment and defining a second lumen having a second cross-sectional dimension, less than the first cross-sectional dimension;a stretch-resistant member disposed within the first lumen; anda rod comprising a proximal portion and a distal portion, the proximal portion having a proximal cross-sectional dimension less than the second cross-sectional dimension, and being configured to extend proximally past the second segment and configured to be received within the second lumen, and the distal portion (i) coupled to the stretch-resistant member, (ii) positioned within the first lumen distal to the second segment, and (iii) having a distal cross-sectional dimension greater than the second cross-sectional dimension;wherein the rod is capable of moving completely into the first lumen distal to the second segment.
  • 2. The implant of claim 1, further comprising a retainer engaging a distal end of the first coil segment and coupled to the stretch-resistant member within the first lumen.
  • 3. The implant of claim 1, wherein, within the first lumen, the rod is movable axially with respect to the first coil segment.
  • 4. The implant of claim 1, wherein the second coil segment has an outer cross-sectional dimension less than or equal to the first cross-sectional dimension.
  • 5. The implant of claim 1, wherein a proximal end of the first coil segment is adjacent to or partially envelopes a distal end of the second coil segment.
  • 6. The implant of claim 1, wherein the first coil segment and the second coil segment each comprise a metal wire.
  • 7. The implant of claim 1, wherein the first coil segment and the second coil segment comprise a primary helix that is predisposed to conform to a secondary shape when unrestrained.
  • 8. The implant of claim 7, wherein the secondary shape is selected from helical, spheroidal, cubic, and tertiary space-filling shapes.
  • 9. A coil implant, comprising: a first coil segment defining a first lumen;a second coil segment, having at least a portion extending within the first lumen, the second segment being connected to the first segment and defining a second lumen;a stretch-resistant member disposed within the first lumen;a rod comprising a proximal portion and a distal portion, the proximal portion being capable of moving, from a location proximal to the second segment, distally into the second lumen when released from a delivery device, and the distal portion being coupled to the stretch-resistant member in the first lumen distal to the second segment and configured to engage the second segment to limit proximal movement of the distal portion through the second lumen.
  • 10. The implant of claim 9, wherein the first lumen has a first cross-sectional dimension; the second lumen has a second cross-sectional dimension, less than the first cross-sectional dimension; the proximal portion has a proximal cross-sectional dimension less than the second cross-sectional dimension; and the distal portion has a distal cross-sectional dimension greater than the second cross-sectional dimension.
  • 11. The implant of claim 9, wherein the rod is capable of moving completely into the first lumen distal to the second segment.
  • 12. The implant of claim 9, wherein, within the first lumen, the rod is movable axially with respect to the first coil segment.
  • 13. The implant of claim 9, wherein each of the first coil segment and the second coil segment comprise a metal wire.
  • 14. The implant of claim 9, wherein the first coil segment and the second coil segment are comprised of a primary helix that is predisposed to conform to a secondary shape when unrestrained.
  • 15. The implant of claim 14, wherein the secondary shape is selected from helical, spheroidal, cubic, and tertiary space-filling shapes.
  • 16. The implant of claim 9, wherein the proximal portion is capable of moving, from proximal to the second segment, distally into the second lumen when the proximal portion is disengaged from a positioner.
  • 17. A method of treating a vascular site in a patient, comprising: introducing an implant to the site via a positioner, the implant comprising: a first coil segment defining a first lumen;a second coil segment, having at least a portion extending within the first lumen, the second segment being connected to the first segment and defining a second lumen;a stretch-resistant member disposed within the first lumen; anda rod comprising a proximal portion and a distal portion, the proximal portion being coupled with the positioner and the distal portion being coupled to the stretch-resistant member in the first lumen distal to the second segment and configured to engage the second segment to limit proximal movement of the distal portion through the second lumen;positioning the implant at the vascular site while the positioner is coupled with the proximal portion; andreleasing the proximal portion from the positioner, such that the proximal portion moves distally into the second lumen from a location proximal to the second segment.
  • 18. The method of claim 17, wherein the positioner is a micro catheter.
  • 19. The method of claim 17, wherein the releasing the implant from the positioner comprises chemical detachment, electrolytic detachment, mechanical detachment, hydraulic detachment, or thermal detachment.
  • 20. The method of claim 17, wherein the releasing comprises moving a cord proximally to disengage the implant.
  • 21. The method of claim 17, wherein, after the releasing, the rod is entirely contained within the first lumen and distal to the second segment.
  • 22. The method of claim 17, wherein the implant is not stretch-resistant after the releasing.
RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 12/038,730, filed Feb. 27, 2008, which claims the benefit under 35 U.S.C. §119(e) of provisional application Ser. No. 60/894,589 filed Mar. 13, 2007 and 60/894,858 filed on Mar. 14, 2007, each of the above applications being expressly incorporated herein by reference in its entirety.

US Referenced Citations (512)
Number Name Date Kind
3174851 Buehler et al. Mar 1965 A
3334629 Colm Aug 1967 A
3753700 Harrison et al. Aug 1973 A
3834394 Hunter et al. Sep 1974 A
4085757 Pevsner Apr 1978 A
4282875 Serbinenko et al. Aug 1981 A
4311146 Wonder Jan 1982 A
4327734 White, Jr. May 1982 A
4341218 U Jul 1982 A
4346712 Handa et al. Aug 1982 A
4364392 Strother et al. Dec 1982 A
4402319 Handa et al. Sep 1983 A
4441495 Hicswa Apr 1984 A
4494531 Gianturco Jan 1985 A
4517979 Pecenka May 1985 A
4545367 Tucci Oct 1985 A
4638803 Rand Jan 1987 A
4677191 Tanaka et al. Jun 1987 A
4735201 O'Reilly Apr 1988 A
4781177 Lebigot Nov 1988 A
4787899 Lazarus Nov 1988 A
4819637 Dormandy, Jr. et al. Apr 1989 A
4832055 Palestrant May 1989 A
4944746 Iwata et al. Jul 1990 A
4957501 Lahille et al. Sep 1990 A
4990155 Wilkoff Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
5002556 Ishida et al. Mar 1991 A
5026377 Burton et al. Jun 1991 A
5035706 Giantureo et al. Jul 1991 A
5037427 Harada et al. Aug 1991 A
5062829 Pryor et al. Nov 1991 A
5104399 Lazarus Apr 1992 A
5108407 Geremia et al. Apr 1992 A
5109867 Twyford, Jr. May 1992 A
5122136 Guglielmi et al. Jun 1992 A
5133731 Butler et al. Jul 1992 A
5133732 Wiktor Jul 1992 A
5147370 McNamara et al. Sep 1992 A
5167624 Butler et al. Dec 1992 A
5181921 Makita et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5211658 Clouse May 1993 A
5217484 Marks Jun 1993 A
5222970 Reeves Jun 1993 A
5224953 Morgentaler Jul 1993 A
5226911 Chee et al. Jul 1993 A
5234437 Sepetka Aug 1993 A
5250071 Palermo Oct 1993 A
5256146 Ensminger et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5263964 Purdy Nov 1993 A
5282806 Haber et al. Feb 1994 A
5304194 Chee et al. Apr 1994 A
5304195 Twyford, Jr. et al. Apr 1994 A
5312415 Palermo May 1994 A
5314472 Fontaine May 1994 A
5334210 Gianturco Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5354295 Guglielmi et al. Oct 1994 A
5368592 Stern et al. Nov 1994 A
5382259 Phelps et al. Jan 1995 A
5382260 Dormandy, Jr. et al. Jan 1995 A
5382261 Palmaz Jan 1995 A
5397345 Lazarus Mar 1995 A
5417708 Hall et al. May 1995 A
5423829 Pham et al. Jun 1995 A
5423849 Engelson et al. Jun 1995 A
5443454 Tanabe et al. Aug 1995 A
5443478 Purdy Aug 1995 A
5456693 Conston et al. Oct 1995 A
5476472 Dormandy, Jr. et al. Dec 1995 A
5480382 Hammerslag et al. Jan 1996 A
5485496 Lee et al. Jan 1996 A
5498227 Mawad Mar 1996 A
5499985 Hein et al. Mar 1996 A
5507769 Marin et al. Apr 1996 A
5522822 Phelps et al. Jun 1996 A
5522836 Palermo Jun 1996 A
5527338 Purdy Jun 1996 A
5536274 Neuss Jul 1996 A
5540680 Guglielmi et al. Jul 1996 A
5549624 Mirigian et al. Aug 1996 A
5562698 Parker Oct 1996 A
5569245 Guglielmi et al. Oct 1996 A
5573520 Schwartz et al. Nov 1996 A
5578074 Mirigian Nov 1996 A
5582619 Ken Dec 1996 A
5601600 Ton Feb 1997 A
5624449 Pham et al. Apr 1997 A
5624461 Mariant Apr 1997 A
5626599 Bourne et al. May 1997 A
5634928 Fischell et al. Jun 1997 A
5639277 Mariant et al. Jun 1997 A
5643254 Scheldrup et al. Jul 1997 A
5645558 Horton Jul 1997 A
5645564 Northrup et al. Jul 1997 A
5649949 Wallace et al. Jul 1997 A
5658308 Snyder Aug 1997 A
5662700 Lazarus Sep 1997 A
5669905 Scheldrup et al. Sep 1997 A
5669931 Kupiecki et al. Sep 1997 A
5690666 Berenstein et al. Nov 1997 A
5690667 Gia Nov 1997 A
5690671 McGurk et al. Nov 1997 A
5693067 Purdy Dec 1997 A
5695517 Marin et al. Dec 1997 A
5700258 Mirigian et al. Dec 1997 A
5702361 Evans et al. Dec 1997 A
5718711 Berenstein et al. Feb 1998 A
5725534 Rasmussen Mar 1998 A
5725546 Samson Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5733329 Wallace et al. Mar 1998 A
5743905 Eder et al. Apr 1998 A
5746734 Dormandy, Jr. et al. May 1998 A
5746769 Ton et al. May 1998 A
5749891 Ken et al. May 1998 A
5749894 Engelson May 1998 A
5749918 Hogendijk et al. May 1998 A
5759161 Ogawa et al. Jun 1998 A
5766219 Horton Jun 1998 A
5797953 Tekulve Aug 1998 A
5800426 Taki et al. Sep 1998 A
5800453 Gia Sep 1998 A
5800455 Palermo et al. Sep 1998 A
5814062 Sepetka et al. Sep 1998 A
5830230 Berryman et al. Nov 1998 A
5833705 Ken et al. Nov 1998 A
5843118 Sepetka et al. Dec 1998 A
5846210 Ogawa et al. Dec 1998 A
5851206 Guglielmi et al. Dec 1998 A
5853418 Ken et al. Dec 1998 A
5855578 Guglielmi et al. Jan 1999 A
5891058 Taki et al. Apr 1999 A
5891128 Gia et al. Apr 1999 A
5891130 Palermo et al. Apr 1999 A
5891155 Irie Apr 1999 A
5891192 Murayama et al. Apr 1999 A
5895385 Guglielmi et al. Apr 1999 A
5895391 Farnholtz Apr 1999 A
5895410 Forber et al. Apr 1999 A
5895411 Irie Apr 1999 A
5911731 Pham et al. Jun 1999 A
5911737 Lee et al. Jun 1999 A
5916235 Guglielmi Jun 1999 A
5919187 Guglielmi et al. Jul 1999 A
5925037 Guglielmi et al. Jul 1999 A
5925059 Palermo et al. Jul 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5928226 Guglielmi et al. Jul 1999 A
5935145 Villar et al. Aug 1999 A
5935148 Villar et al. Aug 1999 A
5941249 Maynard Aug 1999 A
5941888 Wallace et al. Aug 1999 A
5944714 Guglielmi et al. Aug 1999 A
5944733 Engelson Aug 1999 A
5947962 Guglielmi et al. Sep 1999 A
5947963 Guglielmi Sep 1999 A
5957948 Mariant Sep 1999 A
5964797 Ho Oct 1999 A
5972019 Engelson et al. Oct 1999 A
5976126 Guglielmi Nov 1999 A
5976131 Guglielmi et al. Nov 1999 A
5976152 Regan et al. Nov 1999 A
5976162 Doan et al. Nov 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980550 Eder et al. Nov 1999 A
5980554 Lenker et al. Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
5984944 Forber Nov 1999 A
5989242 Saadat et al. Nov 1999 A
6001092 Mirigian et al. Dec 1999 A
6004338 Ken et al. Dec 1999 A
6010498 Guglielmi Jan 2000 A
6013084 Ken et al. Jan 2000 A
6015424 Rosenbluth et al. Jan 2000 A
6017364 Lazarus Jan 2000 A
6017977 Evans et al. Jan 2000 A
6019757 Scheldrup Feb 2000 A
6022369 Jacobsen et al. Feb 2000 A
6024754 Engelson Feb 2000 A
6024765 Wallace et al. Feb 2000 A
6030413 Lazarus Feb 2000 A
6033423 Ken et al. Mar 2000 A
6039749 Marin et al. Mar 2000 A
6056770 Epstein et al. May 2000 A
6059779 Mills May 2000 A
6059815 Lee et al. May 2000 A
6063070 Eder May 2000 A
6063100 Diaz et al. May 2000 A
6063104 Villar et al. May 2000 A
6066133 Guglielmi et al. May 2000 A
6066149 Samson et al. May 2000 A
6068644 Lulo et al. May 2000 A
6074407 Levine et al. Jun 2000 A
6077260 Wheelock et al. Jun 2000 A
D427680 Mariant et al. Jul 2000 S
6083220 Guglielmi et al. Jul 2000 A
6086577 Ken et al. Jul 2000 A
6090125 Horton Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096034 Kupiecki et al. Aug 2000 A
6096546 Raskin Aug 2000 A
6102917 Maitland et al. Aug 2000 A
6102932 Kurz Aug 2000 A
6102933 Lee et al. Aug 2000 A
6113622 Hieshima Sep 2000 A
6117142 Goodson et al. Sep 2000 A
6123714 Gia et al. Sep 2000 A
6126672 Berryman et al. Oct 2000 A
6136015 Kurz et al. Oct 2000 A
6143007 Mariant et al. Nov 2000 A
6146373 Cragg et al. Nov 2000 A
6149664 Kurz Nov 2000 A
6149681 Houser et al. Nov 2000 A
6156061 Wallace et al. Dec 2000 A
6159165 Ferrera et al. Dec 2000 A
6159206 Ogawa Dec 2000 A
6165178 Bashiri et al. Dec 2000 A
6165193 Greene, Jr. et al. Dec 2000 A
6165198 McGurk et al. Dec 2000 A
6168570 Ferrera Jan 2001 B1
6168592 Kupiecki et al. Jan 2001 B1
6168610 Marin et al. Jan 2001 B1
6168615 Ken et al. Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6171326 Ferrera et al. Jan 2001 B1
6183491 Lulo Feb 2001 B1
6183495 Lenker et al. Feb 2001 B1
6187024 Boock et al. Feb 2001 B1
6187027 Mariant et al. Feb 2001 B1
6190373 Palermo et al. Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
6193728 Ken et al. Feb 2001 B1
RE37117 Palermo Mar 2001 E
6202261 Moore et al. Mar 2001 B1
6203547 Nguyen et al. Mar 2001 B1
6221066 Ferrera et al. Apr 2001 B1
6221086 Forber Apr 2001 B1
6224610 Ferrera May 2001 B1
6231573 Amor et al. May 2001 B1
6231586 Mariant May 2001 B1
6231590 Slaikeu et al. May 2001 B1
6231597 Deem et al. May 2001 B1
6238403 Greene, Jr. et al. May 2001 B1
6238415 Sepetka et al. May 2001 B1
6241691 Ferrera et al. Jun 2001 B1
6254592 Samson et al. Jul 2001 B1
6270495 Palermo Aug 2001 B1
6277125 Barry et al. Aug 2001 B1
6277126 Barry et al. Aug 2001 B1
6280457 Wallace et al. Aug 2001 B1
6281263 Evans et al. Aug 2001 B1
6287315 Wijeratne et al. Sep 2001 B1
6287318 Villar et al. Sep 2001 B1
6293960 Ken Sep 2001 B1
6296622 Kurz et al. Oct 2001 B1
6299619 Greene, Jr. et al. Oct 2001 B1
6299627 Eder et al. Oct 2001 B1
6306153 Kurz et al. Oct 2001 B1
6312405 Meyer et al. Nov 2001 B1
6312421 Boock Nov 2001 B1
6315709 Garibaldi et al. Nov 2001 B1
6319267 Kurz Nov 2001 B1
6322576 Wallace et al. Nov 2001 B1
6331184 Abrams Dec 2001 B1
6335384 Evans et al. Jan 2002 B1
6344041 Kupiecki et al. Feb 2002 B1
6344048 Chin et al. Feb 2002 B1
6346091 Jacobsen et al. Feb 2002 B1
6348041 Klint Feb 2002 B1
6361547 Hieshima Mar 2002 B1
6364823 Garibaldi et al. Apr 2002 B1
6368338 Konya et al. Apr 2002 B1
6371972 Wallace et al. Apr 2002 B1
6375606 Garibaldi et al. Apr 2002 B1
6375628 Zadno-Azizi et al. Apr 2002 B1
6375668 Gifford et al. Apr 2002 B1
6375669 Rosenbluth et al. Apr 2002 B1
6379329 Naglreiter et al. Apr 2002 B1
6379374 Hieshima et al. Apr 2002 B1
6383146 Klint May 2002 B1
6383174 Eder May 2002 B1
6383204 Ferrera et al. May 2002 B1
6383205 Samson et al. May 2002 B1
6409721 Wheelock et al. Jun 2002 B1
6416535 Lazarus Jul 2002 B1
6416541 Denardo Jul 2002 B2
6423085 Murayama et al. Jul 2002 B1
6425893 Guglielmi Jul 2002 B1
6425914 Wallace et al. Jul 2002 B1
6428557 Hilaire Aug 2002 B1
6428558 Jones et al. Aug 2002 B1
6454780 Wallace Sep 2002 B1
6458119 Berenstein et al. Oct 2002 B1
6458127 Truckai et al. Oct 2002 B1
6458137 Klint Oct 2002 B1
6464699 Swanson Oct 2002 B1
6468266 Bashiri et al. Oct 2002 B1
6475169 Ferrera Nov 2002 B2
6475227 Burke et al. Nov 2002 B2
6478773 Gandhi et al. Nov 2002 B1
6485524 Strecker Nov 2002 B2
6494884 Gifford, III et al. Dec 2002 B2
6500149 Gandhi et al. Dec 2002 B2
6500190 Greene, Jr. et al. Dec 2002 B2
6506204 Mazzocchi Jan 2003 B2
6511468 Cragg et al. Jan 2003 B1
6514264 Naglreiter Feb 2003 B1
6530934 Jacobsen et al. Mar 2003 B1
6533801 Wallace et al. Mar 2003 B2
6537293 Berryman et al. Mar 2003 B1
6540657 Cross, III et al. Apr 2003 B2
6544163 Wallace et al. Apr 2003 B2
6544225 Lulo et al. Apr 2003 B1
6544268 Lazarus Apr 2003 B1
6544275 Teoh Apr 2003 B1
6547804 Porter et al. Apr 2003 B2
6551305 Ferrera et al. Apr 2003 B2
6551340 Konya et al. Apr 2003 B1
6554849 Jones et al. Apr 2003 B1
6558367 Cragg et al. May 2003 B1
6569179 Teoh et al. May 2003 B2
6572628 Dominguez et al. Jun 2003 B2
6575994 Marin et al. Jun 2003 B1
6585748 Jeffree Jul 2003 B1
6585754 Wallace et al. Jul 2003 B2
6589227 Sønderskov Klint Jul 2003 B2
6589230 Gia et al. Jul 2003 B2
6589236 Wheelock et al. Jul 2003 B2
6589265 Palmer et al. Jul 2003 B1
6592605 Lenker et al. Jul 2003 B2
6602261 Greene, Jr. et al. Aug 2003 B2
6602269 Wallace et al. Aug 2003 B2
6603994 Wallace et al. Aug 2003 B2
6605101 Schaefer et al. Aug 2003 B1
6607538 Ferrera et al. Aug 2003 B1
6607539 Hayashi et al. Aug 2003 B1
6610085 Lazarus Aug 2003 B1
6613074 Mitelberg et al. Sep 2003 B1
6616617 Ferrera et al. Sep 2003 B1
6620152 Guglielmi Sep 2003 B2
6623493 Wallace et al. Sep 2003 B2
6632241 Hancock et al. Oct 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6635069 Teoh et al. Oct 2003 B1
6638291 Ferrera et al. Oct 2003 B1
6638293 Makower et al. Oct 2003 B1
6656173 Palermo Dec 2003 B1
6656201 Ferrera et al. Dec 2003 B2
6656218 Denardo et al. Dec 2003 B1
6656351 Boyle Dec 2003 B2
6660020 Wallace et al. Dec 2003 B2
6663607 Slaikeu et al. Dec 2003 B2
6679903 Kurz Jan 2004 B2
6685653 Ehr et al. Feb 2004 B2
6689141 Ferrera et al. Feb 2004 B2
6692510 West Feb 2004 B2
6702844 Lazarus Mar 2004 B1
6716238 Elliott Apr 2004 B2
6723112 Ho et al. Apr 2004 B2
6743236 Barry et al. Jun 2004 B2
6743251 Eder Jun 2004 B1
6766219 Hasey Jul 2004 B1
6767358 Leonhardt et al. Jul 2004 B2
6811561 Diaz et al. Nov 2004 B2
6814748 Baker et al. Nov 2004 B1
6835185 Ramzipoor et al. Dec 2004 B2
6849081 Sepetka et al. Feb 2005 B2
6852116 Leonhardt et al. Feb 2005 B2
6853418 Suzuki et al. Feb 2005 B2
6855153 Saadat Feb 2005 B2
6855155 Denardo et al. Feb 2005 B2
6860893 Wallace et al. Mar 2005 B2
6860901 Baker et al. Mar 2005 B1
6872218 Ferrera et al. Mar 2005 B2
6878163 Denardo et al. Apr 2005 B2
6905503 Gifford, III et al. Jun 2005 B2
6913618 Denardo et al. Jul 2005 B2
6929654 Teoh et al. Aug 2005 B2
6945956 Waldhauser et al. Sep 2005 B2
6958061 Truckai et al. Oct 2005 B2
6958068 Hieshima Oct 2005 B2
6964657 Cragg et al. Nov 2005 B2
6966892 Gandhi et al. Nov 2005 B2
6994689 Zadno-Azizi et al. Feb 2006 B1
6994711 Hieshima et al. Feb 2006 B2
7014645 Greene, Jr. et al. Mar 2006 B2
7029486 Schaefer et al. Apr 2006 B2
7029487 Greene, Jr. et al. Apr 2006 B2
7033374 Schaefer et al. Apr 2006 B2
7058456 Pierce Jun 2006 B2
7060083 Gerberding Jun 2006 B2
7070607 Murayama et al. Jul 2006 B2
7147618 Kurz Dec 2006 B2
7169161 Bonnette et al. Jan 2007 B2
7182774 Barry et al. Feb 2007 B2
7198613 Gandhi et al. Apr 2007 B2
7238194 Monstadt et al. Jul 2007 B2
7300458 Henkes et al. Nov 2007 B2
7316701 Ferrera et al. Jan 2008 B2
7323000 Monstdt et al. Jan 2008 B2
7331973 Gesswein et al. Feb 2008 B2
7344558 Lorenzo et al. Mar 2008 B2
7410482 Murphy et al. Aug 2008 B2
7422569 Wilson et al. Sep 2008 B2
7473266 Glaser Jan 2009 B2
7485122 Teoh Feb 2009 B2
7485317 Murayama et al. Feb 2009 B1
7524322 Monstdt et al. Apr 2009 B2
7575582 Gandhi et al. Aug 2009 B2
7578826 Gandhi et al. Aug 2009 B2
RE41029 Guglielmi et al. Dec 2009 E
7691124 Balgobin Apr 2010 B2
7708755 Davis, III et al. May 2010 B2
7722636 Farnan May 2010 B2
7722637 Barry et al. May 2010 B2
7811305 Balgobin et al. Oct 2010 B2
7879064 Monstadt et al. Feb 2011 B2
7896899 Patterson et al. Mar 2011 B2
7901444 Slazas Mar 2011 B2
7918872 Mitelberg et al. Apr 2011 B2
8267955 Patterson et al. Sep 2012 B2
20020010481 Jayaraman Jan 2002 A1
20020065529 Laurent et al. May 2002 A1
20020072712 Nool et al. Jun 2002 A1
20020072791 Eder et al. Jun 2002 A1
20020082620 Lee Jun 2002 A1
20020087184 Eder et al. Jul 2002 A1
20020120297 Shadduck Aug 2002 A1
20020128671 Wallace et al. Sep 2002 A1
20020138095 Mazzocchi et al. Sep 2002 A1
20020143349 Gifford et al. Oct 2002 A1
20020169473 Sepetka et al. Nov 2002 A1
20030014073 Bashiri et al. Jan 2003 A1
20030040733 Cragg et al. Feb 2003 A1
20030045901 Opolski Mar 2003 A1
20030083676 Wallace May 2003 A1
20030130689 Wallace et al. Jul 2003 A1
20030169473 Cotter et al. Sep 2003 A1
20030171770 Kusleika et al. Sep 2003 A1
20030176857 Lee Sep 2003 A1
20030181927 Wallace Sep 2003 A1
20030225365 Greff et al. Dec 2003 A1
20040002731 Aganon et al. Jan 2004 A1
20040002732 Teoh et al. Jan 2004 A1
20040002733 Teoh Jan 2004 A1
20040024394 Wallace et al. Feb 2004 A1
20040034363 Wilson et al. Feb 2004 A1
20040034378 Monstadt et al. Feb 2004 A1
20040078050 Monstadt et al. Apr 2004 A1
20040098029 Teoh et al. May 2004 A1
20040106946 Ferrera et al. Jun 2004 A1
20040170685 Carpenter et al. Sep 2004 A1
20040181256 Glaser Sep 2004 A1
20040193178 Nikolchev Sep 2004 A1
20040193206 Gerberding et al. Sep 2004 A1
20040220563 Eder Nov 2004 A1
20040220585 Nikolchev Nov 2004 A1
20040225279 Raymond Nov 2004 A1
20050021023 Guglielmi et al. Jan 2005 A1
20050079196 Henkes et al. Apr 2005 A1
20050222603 Andreas et al. Oct 2005 A1
20060025801 Lulo et al. Feb 2006 A1
20060025802 Sowers Feb 2006 A1
20060036281 Patterson et al. Feb 2006 A1
20060079926 Desai et al. Apr 2006 A1
20060116714 Sepetka et al. Jun 2006 A1
20060135986 Wallace et al. Jun 2006 A1
20060271097 Ramzipoor et al. Nov 2006 A1
20060276824 Mitelberg et al. Dec 2006 A1
20070055302 Henry et al. Mar 2007 A1
20070173757 Levine et al. Jul 2007 A1
20070185524 Diaz et al. Aug 2007 A1
20070239193 Simon et al. Oct 2007 A1
20080045922 Cragg et al. Feb 2008 A1
20080045997 Balgobin et al. Feb 2008 A1
20080051803 Monjtadt et al. Feb 2008 A1
20080086163 Jones et al. Apr 2008 A1
20080097462 Mitelberg et al. Apr 2008 A1
20080103585 Monstadt et al. May 2008 A1
20080125855 Henkes et al. May 2008 A1
20080220216 Unger et al. Sep 2008 A1
20080228215 Strauss et al. Sep 2008 A1
20080228216 Strauss et al. Sep 2008 A1
20080243106 Coe et al. Oct 2008 A1
20080300616 Que et al. Dec 2008 A1
20080306504 Win et al. Dec 2008 A1
20080319532 Monstadt et al. Dec 2008 A1
20090177261 Teoh et al. Jul 2009 A1
20090182268 Thielen et al. Jul 2009 A1
20090254111 Monstadt et al. Oct 2009 A1
20090254169 Spenser et al. Oct 2009 A1
20090270877 Johnson et al. Oct 2009 A1
20090312748 Johnson et al. Dec 2009 A1
20100004673 Denison et al. Jan 2010 A1
20100023105 Levy et al. Jan 2010 A1
20100030200 Strauss et al. Feb 2010 A1
20100049165 Sutherland et al. Feb 2010 A1
20100076479 Monstadt Mar 2010 A1
20100174269 Tompkins et al. Jul 2010 A1
20110022003 Tekulve Jan 2011 A1
20110098814 Monstadt et al. Apr 2011 A1
20110118777 Patterson et al. May 2011 A1
20110172700 Bose et al. Jul 2011 A1
20120041470 Shrivastava et al. Feb 2012 A1
20120065720 Strauss et al. Mar 2012 A1
20120116442 Monstadt et al. May 2012 A1
20120226305 Strauss et al. Sep 2012 A1
20120313447 Park et al. Dec 2012 A1
Foreign Referenced Citations (148)
Number Date Country
1668250 Sep 2005 CN
4445715 Jun 1996 DE
69627243 Jan 1997 DE
19547617 Sep 1997 DE
19607451 Sep 1997 DE
19610333 Sep 1997 DE
19647280 May 2001 DE
19952387 May 2001 DE
10010840 Sep 2001 DE
10118017 Oct 2002 DE
10155191 May 2003 DE
10337000 Mar 2005 DE
0368571 May 1990 EP
707830 Apr 1996 EP
711 532 May 1996 EP
717969 Jun 1996 EP
720 838 Jul 1996 EP
765636 Jul 1997 EP
0792623 Sep 1997 EP
0800791 Oct 1997 EP
820 726 Jan 1998 EP
830 873 Mar 1998 EP
829236 Mar 1998 EP
853 955 Jul 1998 EP
865 773 Sep 1998 EP
882 428 Sep 1998 EP
904 737 Mar 1999 EP
914 807 May 1999 EP
941 700 Sep 1999 EP
941 701 Sep 1999 EP
992 220 Apr 2000 EP
1005837 Jun 2000 EP
1 120 088 Aug 2001 EP
1 125 553 Aug 2001 EP
1 129 666 Sep 2001 EP
1 142 535 Oct 2001 EP
1 169 969 Jan 2002 EP
1 188 413 Mar 2002 EP
1 188 414 Mar 2002 EP
1 312 312 May 2003 EP
1 316 293 Jun 2003 EP
1 358 850 Nov 2003 EP
1 669 032 Jun 2006 EP
1738698 Jan 2007 EP
832 607 Apr 2008 EP
6-246004 Sep 1994 JP
7-155331 Jun 1995 JP
7-265431 Oct 1995 JP
7-284534 Oct 1995 JP
9-168541 Jun 1997 JP
10-201766 Aug 1998 JP
11-47138 Feb 1999 JP
11-76249 Mar 1999 JP
2001-513389 Sep 2001 JP
2002-523172 Jul 2002 JP
2004-500929 Jan 2004 JP
2006-051349 Feb 2006 JP
2008-525113 Jul 2008 JP
WO-8803817 Jun 1988 WO
WO-8906984 Aug 1989 WO
WO-9012616 Nov 1990 WO
WO-9113592 Sep 1991 WO
WO-9214408 Sep 1992 WO
WO-9221400 Dec 1992 WO
WO-9311719 Jun 1993 WO
WO-9316650 Sep 1993 WO
WO-9406502 Mar 1994 WO
WO-9406503 Mar 1994 WO
WO-9410936 May 1994 WO
WO-9411051 May 1994 WO
WO-9426175 Nov 1994 WO
WO-9512367 May 1995 WO
WO-9618343 Jun 1996 WO
WO-9632153 Oct 1996 WO
WO-9639950 Dec 1996 WO
WO-9727888 Aug 1997 WO
WO-9742881 Nov 1997 WO
WO-9809570 Mar 1998 WO
WO 9817183 Apr 1998 WO
WO-9833452 Aug 1998 WO
WO-9834546 Aug 1998 WO
WO-9839048 Sep 1998 WO
WO-9858590 Dec 1998 WO
WO-9902094 Jan 1999 WO
WO-9905977 Feb 1999 WO
WO-9907292 Feb 1999 WO
WO-9909893 Mar 1999 WO
WO-9932037 Jul 1999 WO
WO-9940852 Aug 1999 WO
WO-9942038 Aug 1999 WO
WO-9944538 Sep 1999 WO
WO-9951151 Oct 1999 WO
WO-9956636 Nov 1999 WO
WO-9949812 Dec 1999 WO
WO-0012016 Mar 2000 WO
WO-0013593 Mar 2000 WO
WO-0025680 May 2000 WO
WO-0044306 Aug 2000 WO
WO-0072781 Dec 2000 WO
WO-0132085 May 2001 WO
WO-0156500 Aug 2001 WO
WO-0158365 Aug 2001 WO
WO-0158382 Aug 2001 WO
WO-0187184 Nov 2001 WO
WO-0193937 Dec 2001 WO
WO-0202018 Jan 2002 WO
WO-0213705 Feb 2002 WO
WO-0213706 Feb 2002 WO
WO-0232496 Apr 2002 WO
WO-0239911 May 2002 WO
WO-0241753 May 2002 WO
WO-0245596 Jun 2002 WO
WO-02054943 Jul 2002 WO
WO-02054980 Jul 2002 WO
WO-02072168 Sep 2002 WO
WO-02087449 Nov 2002 WO
WO-02087651 Nov 2002 WO
WO-02089676 Nov 2002 WO
WO-02096273 Dec 2002 WO
WO-02096301 Dec 2002 WO
WO-03001970 Jan 2003 WO
WO-03007823 Jan 2003 WO
WO-03017852 Mar 2003 WO
WO-03034927 May 2003 WO
WO-03039624 May 2003 WO
WO-03041615 May 2003 WO
WO-03053257 Jul 2003 WO
WO-03053281 Jul 2003 WO
WO-03072179 Sep 2003 WO
WO-03073914 Sep 2003 WO
WO-03077776 Sep 2003 WO
WO-03077984 Sep 2003 WO
WO-03082128 Oct 2003 WO
WO-03086240 Oct 2003 WO
WO-03092547 Nov 2003 WO
WO-03099370 Dec 2003 WO
WO-2004008974 Jan 2004 WO
WO-2004014239 Feb 2004 WO
WO-2004069059 Aug 2004 WO
WO-2004073529 Sep 2004 WO
WO-2005113035 Dec 2005 WO
WO-2006032291 Mar 2006 WO
WO-2006069123 Jun 2006 WO
WO-2007121405 Oct 2007 WO
WO-2008112435 Sep 2008 WO
WO-2008112436 Sep 2008 WO
WO-2010117883 Oct 2010 WO
WO-2010123821 Oct 2010 WO
Non-Patent Literature Citations (3)
Entry
U.S. Appl. No. 13/308,476, filed Nov. 30, 2011.
Henkes et al., Neurosurgery 54, No. 2, 268 (2004).
Middleton, J.C. & Tipton, A.J. Synthetic biodegradable polymers as orthopedic devices, Biomaterials 21, 2335-46 (2000).
Related Publications (1)
Number Date Country
20130331883 A1 Dec 2013 US
Provisional Applications (2)
Number Date Country
60894589 Mar 2007 US
60894858 Mar 2007 US
Continuations (1)
Number Date Country
Parent 12038730 Feb 2008 US
Child 13685754 US